{"ORPHApacket":[{"ORPHApacketID":"52530","date":"2019-12-05 17:52:12","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"52530","Name":[{"lang":"en","label":"Pseudo-von Willebrand disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_52530","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare hemorrhagic disorder due to a qualitative platelet defect"}],"ORPHA":"275736","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_275736"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Platelet type Von Willebrand disease (PT-VWD) is a bleeding disorder characterized by mild to moderate mucocutaneous bleeding, which becomes more pronounced during pregnancy or following ingestion of drugs that have anti-platelet activity. PT-VWD is due to hyperresponsive platelets, resulting in thrombocytopenia."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"177820","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal dominant"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"PT-VWD"},{"lang":"en","label":"Platelet type-von Willebrand disease"},{"lang":"en","label":"Pseudo-von Willebrand disease type 2B"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"glycoprotein Ib platelet subunit alpha"}],"Symbol":"GP1BA","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"4439"},{"Source":"OMIM","Reference":"606672"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317343","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) in"}]}]}]}]}]}